Acumen Pharmaceuticals, Inc. Stock Forecast

Acumen Pharmaceuticals, Inc. stock downgraded to Strong Sell Candidate
(Updated on Jun 25, 2024)

ABOS Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Acumen Pharmaceuticals, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.34 and $3.03. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, May 20, 2024, and so far it has fallen -44.27%. Further fall is indicated until a new bottom pivot has been found. Acumen Pharmaceuticals, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Acumen Pharmaceuticals, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.145 between high and low, or 6.78%. For the last week, the stock has had daily average volatility of 6.98%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ABOS) For The Upcoming Trading Day Of Wednesday 26th

For the upcoming trading day on Wednesday, 26th we expect Acumen Pharmaceuticals, Inc. to open at $2.19, and during the day (based on 14 day Average True Range), to move between $1.96 and $2.32, which gives a possible trading interval of +/-$0.180 (+/-8.39%) up or down from last closing price. If Acumen Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 16.78% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $2.49, some $0.350 (16.36%) from the current price of $2.14, our system finds the risk reward not very attractive.

Is Acumen Pharmaceuticals, Inc. stock A Buy?

Acumen Pharmaceuticals, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.910 Strong Sell Candidate Downgraded

Predicted Opening Price for Acumen Pharmaceuticals, Inc. of Wednesday, June 26, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.